The pharmaceutical industry has experienced an unprecedented shift over the past five years with the growth of biologics outpacing that of small molecule drugs.1 Complex biologics have brought innovative new treatment options to patients with many chronic illnesses, including rheumatoid arthritis, Crohn’s disease, and certain cancers. Industry analysts predict that biologics will continue to experience rapid…